| |
This
edition of Glycosmedia is sponsored by Oxford University Press |
| |
|
 |
A selection of books from Oxford University
Press: |
| |
Diabetes |
| |
Diabetes
Care - A Practical Manual |
| |
Oxford
Handbook of Endocrinology and Diabetes |
| |
Oxford
Handbook of Diabetes Nursing |
| |
Diabetes:
The Biography |
| |
|
|
World
Diabetes Day - November 14 |
| |
The World Diabetes Day campaign is led by the International
Diabetes Federation (IDF) and its member associations. It engages millions of people worldwide in
diabetes advocacy and awareness (World Diabetes Day) |
| |
|
|
World
Diabetes Day videos launched on YouTube |
| |
The International Diabetes Federation has just
launched two short videos setting the stage for World Diabetes
Day on 14 November (World Diabetes Day) |
| |
|
|
2009
Annual Evidence Update on Diabetes |
| |
Results of our third Annual Evidence Update
which identifies new systematic reviews on diabetes published between
September 2008 and September 2009 (NHS Evidence - Diabetes ) |
| |
|
|
EFSD/Novo
Nordisk partnership for diabetes research in Europe |
| |
The European Foundation for the Study of Diabetes
(EFSD), the research Foundation of EASD, and Novo Nordisk are pleased to announce their support of diabetes research
with the contribution of 3 million euros over the next three years
(Novo Nordisk) |
| |
|
|
Computer
device 'helps' diabetics |
| |
A handheld computer console game has been developed
to help diabetic children monitor their condition (BBC, UK) |
| |
|
|
Research
matters |
| |
Download of the latest issue - Research matters
Autumn 2009 (Diabetes, UK) |
| |
|
|
Prediction
of Coronary Heart Disease Risk in a General, Pre-Diabetic, and
Diabetic Population During 10 Years of Follow-up |
| |
The use of the Framingham function for prediction
of the first CHD event is likely to overestimate an individual's
absolute CHD risk. In CHD prevention, application of the SCORE
and UKPDS functions might be useful in the absence of a more valid
tool (Diabetes Care) |
| |
|
|
No
Benefits of Aspirin for Primary Prevention in Diabetics, Meta-Analysis
Suggests |
| |
Another meta-analysis--this one focused on diabetics--is
questioning the role of aspirin for the primary prevention of cardiovascular
events (Medscape) |
| |
|
|
Successes
and challenges of insulin therapy for type 2 diabetes in a managed-care
setting |
| |
Insulin is effective when used per ADA-EASD
guidelines but health plans wishing to optimize diabetes care may
need to intensify insulin therapy or consider the use of adjunct
therapies in the years after initiation (Current Medical Research
and Opinion) |
| |
|
|
Alogliptin
added to insulin therapy in patients with type 2 diabetes reduces
HbA1c without causing weight gain or increased hypoglycaemia |
| |
Adding alogliptin to previous insulin therapy
(with or without metformin) significantly improved glycaemic control
in patients with type 2 diabetes inadequately controlled on insulin,
without causing weight gain or increasing the incidence of hypoglycaemia
(Diabetes, Obesity and Metabolism) |
| |
|
|
Patient-reported
outcomes in a survey of patients treated with oral antihyperglycaemic
medications: |
| |
Among patients with type 2 diabetes treated
with OAHAs, self-reported hypoglycaemia and weight gain were associated
with decreased treatment satisfaction and HRQoL. In addition, the
presence of these SEs was associated with increased fear of hypoglycaemia
(Diabetes, Obesity and Metabolism) |
| |
|
|
FDA
Working to Revise Prescribing Information for Diabetes Medications |
| |
The FDA is revising the prescribing information
for the injectable diabetes medication exenatide and the oral diabetes
drug sitagliptin phosphate following reports of renal problems
associated with exenatide use, as well as reports linking sitagliptin
use with pancreatitis (AAFP) |
| |
|
|
Free
Diabetes UK 'Diabetes Care and You' leaflets for GPs and their
patients |
| |
Diabetes UK, in partnership with NHS Diabetes,
has produced 'Diabetes Care and You' – a booklet to provide key information to people with diabetes about their role
in managing their diabetes, working together with their healthcare
team, and what they should expect from the NHS Free download (Diabetes UK) |
| |
|
|
Diabetes
and obesity in older adults: a call to action |
| |
This call to action discusses comorbidities
associated with type 2 diabetes and obesity in the older population
and its impact on patients (Reviews in Clinical Gerontology) |
| |
|
|
A
'radical' new rural model for pediatric diabetes care |
| |
Multidisciplinary child diabetes care can be
successfully achieved in rural settings using local resources with
results comparable to international tertiary multidisciplinary
diabetes units (Pediatric Diabetes) |
| |
|
|
Saxagliptin
Added to a Thiazolidinedione Improves Glycemic Control in Patients
with Type 2 Diabetes and Inadequate Control on Thiazolidinedione
Alone |
| |
Saxagliptin added to TZD provided statistically
significant improvements in key parameters of glycemic control
vs. TZD monotherapy and was generally well tolerated (Journal of
Clinical Endocrinology & Metabolism) |
| |
|
|
Effect
of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers
in Patients with Type 2 Diabetes |
| |
Commonly measured bone biomarkers suggest that
changes in bone resorption may be partly responsible for the increased
risk of fracture in women taking thiazolidinedione (Journal of
Clinical Endocrinology & Metabolism) |
| |
|
|
Sodium
Glucose Cotransporter 2 Inhibitors as a New Treatment for Diabetes
Mellitus |
| |
SGLT2 inhibitors are showing promise as a useful
addition to the current therapeutic options in type 2 diabetes
mellitus. Results of ongoing phase III clinical trials are awaited
and will determine whether the risk-benefit ratio will allow approval
of this new class of drug for the management of type 2 diabetes
mellitus (Journal of Clinical Endocrinology & Metabolism) |
| |
|
|
Pilot
Evaluation of a Prototype Critical Care Blood Glucose Monitor
in Normal Volunteers |
| |
Automated phlebotomy can be performed in healthy
subjects using this prototype BG monitor. The BG measurement technology
had suboptimal accuracy based on a YSI reference. A more accurate
BG point-of care testing meter and strip technology have been incorporated
into the future version of this monitor (Journal of Diabetes Science
and Technology) |
| |
|
|
The
Impact of Diabetes Type 2 in the Pathogenesis of Benign Prostatic
Hyperplasia: A Review |
| |
The exact relationship of BPH to diabetes remains
unclear. The specific pathway interfering in the development of
both conditions is still poorly investigated. However, evidence
suggests that an association between BPH and diabetes through a
common pathogenic mechanism through male hormone activity alteration
mediated by IGF is possible (Advances in Urology) |
| |
|
|
Software
for transfer of data between diabetic retinal screening services
and hospital eye services |
| |
Digital Healthcare, the leading supplier of
software to UK diabetic retinal screening services (DRSS) and Medisoft,
a leading supplier of software to UK hospital eye services (HES),
are collaborating to develop Medisoft Connector, a software module
that will allow the two-way transfer of patient and outcome data
between their respective systems (British Journal of Healthcare
Computing & Information Management) |
| |
|
